These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24335551)

  • 41. Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs.
    Dixon-Jimenez AC; Brainard BM; Cathcart CJ; Koenig A
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):402-7. PubMed ID: 23796019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Point-of-care testing for coagulation function: CoaguChek
    Kako H; Raman VT; Tumin D; Rice J; Tobias JD
    J Anesth; 2017 Jun; 31(3):345-350. PubMed ID: 28213667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of point-of-care testing (POCT): i-STAT(®) international normalized ratio (INR) vs reference laboratory INR in pediatric patients undergoing major surgery.
    Spielmann N; Mauch JY; Madjdpour C; Schmugge M; Albisetti M; Weiss M; Haas T
    Paediatr Anaesth; 2011 Oct; 21(10):1041-5. PubMed ID: 21545369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies.
    Reiss RA; Haas CE; Griffis DL; Porter B; Tara MA
    Pharmacotherapy; 2002 Jun; 22(6):677-85. PubMed ID: 12066958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment.
    Riva N; Vella K; Meli S; Hickey K; Zammit D; Calamatta C; Makris M; Kitchen S; Ageno W; Gatt A
    Int J Lab Hematol; 2017 Oct; 39(5):482-488. PubMed ID: 28500649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin.
    Strazzulla A; Chakvetadze C; Picque M; Cassard B; Hernandez F; De Pontfarcy A; Flateau C; Danneels P; Belfeki N; Diamantis S
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):177-183. PubMed ID: 30414092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.
    De Luca R; Fontana P; Poncet A; de Moerloose P; Pfister RE
    Thromb Res; 2014 Aug; 134(2):474-8. PubMed ID: 24951336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interchangeability of activated clotting time values across different point-of-care systems.
    Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
    Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accuracy of international normalized ratio determined by portable venous-blood coagulation monitor versus a central laboratory.
    Sirithunyanont C; Bhuripanyo K; Kangkagate C; Winyarat W; Srichaya P; Wangtip K
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S67-75. PubMed ID: 12866771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality assurance for point-of-care testing of oral anticoagulation: a large-scale evaluation of the Hemochron Junior Signature Microcoagulation System.
    Maddox JM; Bogo PH; McGregor E; Pippard MJ; Kerr R
    Int J Lab Hematol; 2009 Apr; 31(2):142-50. PubMed ID: 18177437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndrome.
    Braham S; Novembrino C; Moia M; Torresani E; Tripodi A
    Int J Lab Hematol; 2016 Oct; 38(5):497-504. PubMed ID: 27321438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
    Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC
    Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.
    Rizos T; Herweh C; Jenetzky E; Lichy C; Ringleb PA; Hacke W; Veltkamp R
    Stroke; 2009 Nov; 40(11):3547-51. PubMed ID: 19696414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
    Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
    Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of point-of-care testing in critically unwell patients: comparison with clinical laboratory analysers and applicability to patients with Ebolavirus infection.
    Kok J; Ng J; Li SC; Giannoutsos J; Nayyar V; Iredell JR; Dwyer DE; Chen SC
    Pathology; 2015 Aug; 47(5):405-9. PubMed ID: 26126049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
    Ero MP; Harvey NR; Harbert JL; Janc JW; Chin KH; Barriere SL
    J Thromb Thrombolysis; 2014; 38(2):235-40. PubMed ID: 24132401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.
    Klein RH; van der Vorst MM; de Wilde RB; Hogenbirk K; de Kam ML; Burggraaf J
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):327-31. PubMed ID: 23337708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.